http___www.takeda.hr_o-nama_takeda-u-svijetu__1.xml
1.1 1.2 2.1 2.2 3.1 3.2 4.1 4.2 4.3 5.1 7.1 8.1 8.2 8.3 9.1 10.1 10.2 10.3 11.1 12.1 14.1
Osaka, Japan, 24 February, 2016 --- Takeda Pharmaceutical Company Limited [TSE: 4502], (“Takeda”) today announced that its Annual Report 2015 and CSR Data Book 2015 received the Good Performance Prize in the Environmental Report Section of the 19th Environmental Communication Awards, co-sponsored by Japan’s Ministry of the Environment and the Global Environmental Forum*. Takeda received the Excellence Prize in 2011, Good Performance Prize in 2014, and this is the second year in a row and third time overall to receive a prize in this award. The Environmental Communication Awards recognize outstanding environmental reports and environmental activity reports to promote companies' efforts in environmental management and environmental communication, and dispatch quality of non-financial information using a new information disclosure framework. This year marks the 19th anniversary of the Environmental Communication Awards. The prize was awarded in recognition of Takeda’s deep understanding of value and capital, the resources of the corporate values, and integration of our long-term management and CSR vision; establishment of strategic CSR and engagement systems with outside partners; and linkage of CSR activity including supply chain management to improvement of the corporate values. Furthermore, the integrated Takeda Annual Report 2015 and CSR Data Book 2015 were recognized for making the connection between corporate value and CSR. Takeda’s management mission is to strive towards better health for people worldwide through leading innovation in medicine. In line with this mission, Takeda puts patients at the center of every activity and believes that CSR is the foundation of any pharmaceutical business. As a pharmaceutical company dedicated to improving people’s lives, Takeda remains committed to the fulfillment of its social responsibility in response to the needs of global society, and aims to produce even better reports in the future with the interests of all its stakeholders firmly in mind. * The Global Environmental Forum is a non-profit environmental organization founded in 1990 to conduct scientific surveys and research on global environmental issues, disseminate and promote such issues to the public, and make policy recommendations. About Takeda’s Annual Report 2015 and CSR Data Book 2015 Since fiscal 2006, Takeda has been publishing its annual report as an integrated report incorporating non-financial information in addition to financial information in order to further improve its accountability to stakeholders. Regarding non-financial information, Takeda issues the CSR Data Book in PDF form, which includes more detailed non-financial information than that which appears in the annual report. (http://www.takeda.com/csr/reports/) About Takeda Pharmaceutical Company Limited Located in Osaka, Japan, Takeda (TSE: 4502) is a research-based global company with its main focus on pharmaceuticals. As the largest pharmaceutical company in Japan and one of the global leaders of the industry, Takeda is committed to strive towards better health for people worldwide through leading innovation in medicine. Additional information about Takeda is available through its corporate website, www.takeda.com. Media Contacts: Tsuyoshi Tada tsuyoshi.tada@takeda.com
1.1 2.1 2.2 2.3 2.4 3.1 4.1 5.1 6.1 7.1 8.1 9.1
Zgrada Takeda Midosuji, sjedište Takeda Pharmaceutical Company, gradski dio Chuo-ku, Osaka, Japan Takedina misija je predvođenjem inovacija u medicini poboljšati zdravlje ljudi diljem svijeta. Takeda je najveća farmaceutska kompanija u Japanu, a posluje i u više od 70 zemalja svijeta. Osobito je snažno prisutna u Aziji, Sjevernoj Americi, Europi i na brzorastućim tržištima, uključujući Latinsku Ameriku, Rusiju i druge države ZND-a te Kinu. Takedini lijekovi prisutni su na tržištima više od 100 zemalja. Po prodaji lijekova na recept, Takeda zauzima 12. mjesto u svijetu, 14. mjesto u zemljama BRIC-a (Brazil, Rusija, Indija i Kina) te 18. mjesto u Europi. Takeda je u okviru svoje djelatnosti prisutna na područjima metaboličkih bolesti, gastroenterologije, onkologije, kardiovaskularnih bolesti, bolesti središnjeg živčanog sustava, upalnih i imunoloških bolesti te liječenja boli. Usmjerena je na plasiranje širokog portfelja proizvoda, poboljšanje prodaje novih proizvoda te neprestano usavršavanje konkurentnih proizvoda u kasnim fazama istraživanja i razvoja. Najnoviji godišnji izvještaj tvrtke Takeda Pharmaceuticals dostupan je ovdje Više podataka o tvrtki Takeda možete pronaći na mrežnim stranicama www.takeda.com. Reference: [1] Godišnji izvještaj tvrtke Takeda Pharmaceutical za 2015. godinu